Aim Bulletin

Cambridge Cognition secures £1m contract with 'major pharmaceutical company'

By Iain Gilbert

Date: Thursday 10 Apr 2025

(Sharecast News) - Software group Cambridge Cognition said on Thursday that it has secured a £1.0m contract to provide digital cognitive assessments for a large Phase 3 autoimmune disease clinical trial.
Cambridge Cognition said the initial contract, which was with "a major pharmaceutical company", will start in 2025 and run through...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page